Improved diagnostic value by combining plasma PON1 level with tumor biomarkers in Colorectal Cancer patients.

Abstract:

:The incidence of colorectal cancer (CRC) ranks third among all cancers in China and improvements in screening for CRC have an important impact on prevention and control of the disease. Paraoxonase 1 (PON1) is a calcium ion-dependent hydrolase that is widely distributed in tissue. Its diagnostic value in colorectal cancer has been reported, but the diagnostic value of combining PON1 with carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 12-5 (CA12-5) in colorectal cancer has not been evaluated. Experiments were carried out in a total of 284 CRC patients and 90 healthy controls. The primary cohort was randomly divided into training and validation sets. The levels of PON1 in plasma of CRC patients were significantly lower than that in the healthy controls (P < 0.001). It showed excellent diagnostic value with the AUC reaching 0.750 for the training set and 0.742 for the validation set. Furthermore, combining PON1 with CEA, CA12-5, CA19-9 could better classify CRC patients (AUC rising from 0.821, 0.716, 0.712 to 0.875, 0.817 and 0.814, respectively, in the training set, from 0.818, 0.581, 0.593 to 0.854, 0.770, and 0.772 in the validation set). In conclusion, PON1 can serve as a diagnostic biomarker for CRC and raise the sensitivity and specificity when incorporated with traditional tumor biomarkers.

journal_name

J Cancer

journal_title

Journal of Cancer

authors

Zhang J,Yang X,Wei L,Tan H,Chen J,Li W,Chan K,Su Y,Zhao L,Hu S,Zhong S,Xiao Y,Liu H

doi

10.7150/jca.45204

subject

Has Abstract

pub_date

2020-09-17 00:00:00

pages

6491-6496

issue

22

issn

1837-9664

pii

jcav11p6491

journal_volume

11

pub_type

杂志文章
  • The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy.

    abstract::Background: The programmed death 1 (PD1)/programmed death ligand 1 (PDL1) targeted therapies have gained positive outcomes in several tumors, but the evidence of the expression and prognosis value of PD1/PDL1 in high risk prostate cancer was rare. Methods: Immunohistochemical analysis of PDL1/PD1 expression by a valid...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.30384

    authors: Li H,Wang Z,Zhang Y,Sun G,Ding B,Yan L,Liu H,Guan W,Hu Z,Wang S,Cheng F,Xu H,Zhang X,Ye Z

    更新日期:2019-06-02 00:00:00

  • Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.

    abstract::Background and aims. Cyclin-dependent kinase inhibitor 3 (CDKN3) has been found playing a varying role in carcinogenesis, but its biological function in esophageal squamous cell carcinoma (ESCC) is unclear. The aim of this study was to demonstrate the role of CDKN3 in ESCC. Materials and Methods: Real-time PCR and Wes...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.27053

    authors: Liu J,Min L,Zhu S,Guo Q,Li H,Zhang Z,Zhao Y,Xu C,Zhang S

    更新日期:2019-04-21 00:00:00

  • Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan.

    abstract::EGFR mutation of Non-small cell lung cancers (NSCLC) was predominantly seen in Asian population and it was considered as a predictor of responsiveness. Eendothelial nitric oxide synthase (eNOS) plays a vital role in chronic inflammation and carcinogenesis. In this study, we aimed to explore the association between the...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25824

    authors: Huang CY,Hsieh MJ,Wu WJ,Chiang WL,Liu TC,Yang SF,Tsao TC

    更新日期:2018-06-15 00:00:00

  • Association between the KRAS Gene Polymorphisms and Papillary Thyroid Carcinoma in a Chinese Han Population.

    abstract::Several studies have reported the association between MAPK signaling pathway gene polymorphisms and papillary thyroid carcinoma (PTC). KRAS gene, an oncogene from the mammalian RAS gene family plays an important role in the MAPK pathway. This study aimed to identify the potential association of KRAS gene polymorphisms...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.16507

    authors: Ning L,Rao W,Yu Y,Liu X,Pan Y,Ma Y,Liu R,Zhang S,Sun H,Yu Q

    更新日期:2016-12-09 00:00:00

  • Neoadjuvant Chemoradiation Treatment for Resectable Esophago-Gastric Cancer: A Systematic Review and Meta-Analysis.

    abstract::Background: Neoadjuvant chemoradiation (CRT) remains controversial in the treatment of the oesophagus or gastro-oesophageal junction (GOJ) carcinomas. Methods: We conducted a meta-analysis to assess the efficacy and safety of Neoadjuvant CRT plus surgery comparing with neoadjuvant CT plus surgery or surgery alone. Fea...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25915

    authors: Meng X,Wang L,Zhao Y,Zhu B,Sun T,Zhang T,Gu X,Zheng Z

    更新日期:2019-01-01 00:00:00

  • Shared liver-like transcriptional characteristics in liver metastases and corresponding primary colorectal tumors.

    abstract::Background & Aims: Primary tumors of colorectal carcinoma (CRC) with liver metastasis might gain some liver-specific characteristics to adapt the liver micro-environment. This study aims to reveal potential liver-like transcriptional characteristics associated with the liver metastasis in primary colorectal carcinoma....

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.23017

    authors: Cheng J,Song X,Ao L,Chen R,Chi M,Guo Y,Zhang J,Li H,Zhao W,Guo Z,Wang X

    更新日期:2018-04-06 00:00:00

  • Effect of TTLL6 expression on CDDP sensitivity of EC109/CDDP cells in hypoxia/acidosis microenvironment.

    abstract::Multidrug resistance is a major obstacle to the effective treatment of esophageal carcinoma. It occurs more readily in hypoxia and acidosis microenvironment. TTLL6 is one of Tubulin tyrosine ligase-like family members. In this study, the effect of TTLL6 on the regulation of cisplatin (CDDP) sensitivity was evaluated i...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.47694

    authors: Qiu Y,Wu C,Li J,Tang M,Zhang S,Jing T,Liao Y,Wang H

    更新日期:2020-09-30 00:00:00

  • Long-term aspirin use for primary cancer prevention: An updated systematic review and subgroup meta-analysis of 29 randomized clinical trials.

    abstract::Background and objective: Long-term aspirin use for the primary prevention of cancer remains controversial, and variations in the effect of aspirin use on cancer outcomes by aspirin dose, follow-up duration, or study population have never been systematically evaluated. The objective of this study was to evaluate the e...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.49001

    authors: Wu Q,Yao X,Chen H,Liu Z,Li T,Fan X,Zhang G,Yu L,Chen M,Xu C,Zhang R,Chen B,Sui X,Leung EL

    更新日期:2020-09-14 00:00:00

  • Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer.

    abstract::Background: Inflammation might play an important role in promoting cancer growth partly by affecting tumor angiogenesis. We explored the role of Glasgow prognostic score (GPS) in metastatic colorectal cancer patients receiving first-linebevacizumab. Methods: All consecutive metastatic colorectal cancer patients treate...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.31182

    authors: Huang Y,Li W,Quan Q,Zhang B,Yang Q

    更新日期:2019-11-15 00:00:00

  • Treating breast cancer in the 21st century: emerging biological therapies.

    abstract::For many years, the medical treatment of breast cancer was reliant solely on cytotoxic chemotherapy. However, over the past twenty years, treatment has evolved to a more target-directed approach. We now employ tailored therapy based on the presence or absence of receptors for estrogen, progesterone, and human epiderma...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.4925

    authors: Tinoco G,Warsch S,Glück S,Avancha K,Montero AJ

    更新日期:2013-01-01 00:00:00

  • Ethanol Enhances Estrogen Mediated Angiogenesis in Breast Cancer.

    abstract::Angiogenesis, a highly regulated process, is exploited by tumors like breast cancer to ensure a constant supply of oxygen and nutrients and is key for tumor survival and progression. Estrogen and alcohol independently have been observed to contribute to angiogenesis in breast cancer but their combinatorial effects hav...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25581

    authors: Maniyar R,Chakraborty S,Suriano R

    更新日期:2018-10-06 00:00:00

  • ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.

    abstract::We discuss the hypothesis that ZEB1-Wnt-p300 signaling integrates epithelial to mesenchymal transition (EMT) and resistance to histone deacetylase inhibitors (HDACis) in colorectal cancer (CRC) cells. The HDACi butyrate, derived from dietary fiber, has been linked to CRC prevention, and other HDACis have been proposed...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.18762

    authors: Lazarova D,Bordonaro M

    更新日期:2017-05-12 00:00:00

  • Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population.

    abstract::Metabolic syndrome has been previously identified as a risk factor for breast cancer and is increasingly a public health concern. This study aims to investigate the prevalence of metabolic syndrome and its components among primary breast cancer and control population. The clinical data of metabolic syndrome and its co...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.22968

    authors: Wu YT,Luo QQ,Li X,Arshad B,Xu Z,Ran L,Zhao CX,Wu H,Shi YL,Chen HR,Li H,Li HY,Wu KN,Kong LQ

    更新日期:2018-01-01 00:00:00

  • Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model.

    abstract::Breast cancer therapy has improved following the development of drugs with specific molecular targets, exemplified by inhibitors of human epidermal growth factor receptor-2 (HER2) or epidermal growth factor receptor (EGFR) such as trastuzumab and lapatinib. However, these drugs have little effect on brain metastasis d...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.6689

    authors: Nakayama A,Takagi S,Yusa T,Yaguchi M,Hayashi A,Tamura T,Kawakita Y,Ishikawa T,Ohta Y

    更新日期:2013-08-16 00:00:00

  • Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status.

    abstract::Clinical outcomes of checkpoint blockade immunotherapy on colorectal cancer (CRC) are influenced by mismatch repair (MMR) gene status, which is associated with distinct tumor immune infiltrates and systemic inflammatory response status. However, the prognostic value of PD-L1 expression and the systemic inflammatory re...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25187

    authors: Kong P,Wang J,Song Z,Liu S,He W,Jiang C,Xie Q,Yang L,Xia X,Xia L

    更新日期:2019-04-05 00:00:00

  • Genetic polymorphisms may influence the vertical growth rate of melanoma.

    abstract::Background: Identification of new predictive markers in melanoma is of great clinical importance. This study was aimed to analyze association between selected common variants in the cancer susceptibility genes and melanoma progression at the time of diagnosis. Material and Method: The study included 243 consecutive pa...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.26404

    authors: Sikora M,Rudnicka L,Borkowska B,Kardynał A,Słowińska M,Rakowska A,Warszawik-Hendzel O,Wiergowska A,Ługowska I,Rutkowski P,Dębniak T,Lubiński J,Olszewska M

    更新日期:2018-08-06 00:00:00

  • Dysbindin facilitates invasion and metastasis by promoting phosphorylation of ERK in epithelial ovarian cancer.

    abstract::Dysbindin has been reported to be correlated with several malignancies. However, the clinical significance and biological role of dysbindin in epithelial ovarian cancer remains largely unknown. Here we demonstrated that the mRNA and protein levels of dysbindin were significantly upregulated in EOC tissues compared wit...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.39269

    authors: Lv X,Guo X,Ru Y,Zhou F,Yang X,Ge J,Li J,Liu S,Jiang K,Chen B

    更新日期:2020-02-21 00:00:00

  • Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis.

    abstract::The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, the prognostic impact of MET gene copy number gain (CNG) has not been consistent among studies. We performed this meta-analysis to evaluate the prognostic value of high MET CNG in patients with NSCLC. A systematic computerized se...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.24980

    authors: Kim JH,Kim HS,Kim BJ

    更新日期:2018-04-23 00:00:00

  • GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathway.

    abstract::Purpose: We examined the effect of GV1001 in castration castration-resistant prostate cancer (CRPC) cell growth and invasion and explored the potential molecular mechanisms of action. Materials and Methods: The in vitro anti-cancer effects of GV1001 in CRPC cells were examined using cell viability assay, TUNEL assay, ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.34859

    authors: Park YH,Jung AR,Kim GE,Kim MY,Sung JW,Shin D,Cho HJ,Ha US,Hong SH,Kim SW,Lee JY

    更新日期:2019-10-17 00:00:00

  • A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.

    abstract:BACKGROUND:Neoadjuvant chemotherapy with concurrent docetaxel, doxorubicin and cyclophosphamide is commonly used for patients with locally advanced breast cancer. Epirubicin is another anthracycline used in breast cancer but the concurrent use of epirubicin and taxane is not well-established. We conducted a single inst...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.3980

    authors: Yao X,Hosenpud J,Chitambar CR,Charlson J,Cheng YC

    更新日期:2012-01-01 00:00:00

  • Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.

    abstract::Inhibition of aberrantly activated pathways cross-talking with hormone receptor (HR) improves response to endocrine therapy in patients with HR-positive advanced breast cancer. We performed a Pubmed database systematic review to ascertain the existence of a better clinical response when combining endocrine therapy wit...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.11566

    authors: Grassadonia A,Caporale M,Tinari N,Zilli M,DeTursi M,Gamucci T,Vici P,Natoli C

    更新日期:2015-05-12 00:00:00

  • RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients.

    abstract::Purpose: To evaluate the detection of gene mutations in bone marrow biopsy and circulating free DNA (cfDNA) from plasma in multiple myeloma (MM). Experimental design: We used cell-free DNA from plasma and bone marrow to test BRAF V600, KRAS G12/G13, NRAS G12/G13 and NRAS Q61 mutations using multiplex assays for drople...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.43729

    authors: Li Q,Huang HJ,Ma J,Wang Y,Cao Z,Karlin-Neumann G,Janku F,Liu Z

    更新日期:2020-03-15 00:00:00

  • Characterization of the Role of the Malate Dehydrogenases to Lung Tumor Cell Survival.

    abstract::Cellular compartmentalization of biochemical processes in eukaryotic cells is critical for many functions including shuttling of reducing equivalents across membranes. Although coordination of metabolic flux between different organelles is vital for cell physiology, its impact on tumor cell survival is not well unders...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.19373

    authors: Zhang B,Tornmalm J,Widengren J,Vakifahmetoglu-Norberg H,Norberg E

    更新日期:2017-07-05 00:00:00

  • Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells.

    abstract:INTRODUCTION:Cyclin D1 (D1) binds to cyclin-dependent kinases (CDK) 4 or 6 to form a holoenzyme that phosphorylates the Rb protein to promote cell cycle progression from G1 to S phase. Therefore, targeting CDK4/6 may be a good strategy for chemotherapy of cancer. We performed a proof-of-principle study to determine the...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.2.36

    authors: Sun Y,Li YX,Wu HJ,Wu SH,Wang YA,Luo DZ,Liao DJ

    更新日期:2011-01-08 00:00:00

  • High expression of calreticulin indicates poor prognosis and modulates cell migration and invasion via activating Stat3 in nasopharyngeal carcinoma.

    abstract::Objective: Emerging evidence suggests that calreticulin (CALR) has great impacts on the tumor formation and progression of various cancers, but the role of CALR remains controversial. We investigated the expression and clinical significance of CALR in nasopharyngeal carcinoma (NPC). Methods: Immunohistochemistry was u...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35362

    authors: Han Y,Liao Q,Wang H,Rao S,Yi P,Tang L,Tian Y,Oyang L,Wang H,Shi Y,Zhou Y

    更新日期:2019-08-29 00:00:00

  • Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder.

    abstract:PURPOSE:Methotrexate, vinblastine, doxorubicin plus cisplatin (MVAC) and gemcitabine plus cisplatin (GC) are both effective first-line chemotherapy. We explore the responsive variables of MVAC and GC for patients with metastatic urothelial carcinoma of bladder (mUCB). MATERIALS AND METHODS:Patients who were initially ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.15213

    authors: Hsieh MC,Huang CH,Chiang PH,Chen YY,Tang Y,Su YL

    更新日期:2016-06-27 00:00:00

  • Increased Prevalence of Esophageal Cancer in Areas with High Levels of Nickel in Farm Soils.

    abstract::Background: Heavy metal pollution in farm soils is a grave concern in Taiwan. Previously, we found the incidence of oral cancer (OC) correlated positively with levels of nickel and arsenic in farm soils. Many OC patients have a second malignancy, among which esophageal cancer (EC) is the most common one in Taiwan. Obj...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.15441

    authors: Lee CP,Lee YH,Lian IB,Su CC

    更新日期:2016-08-06 00:00:00

  • A Predictive Nomogram for Early Death of Metastatic Gastric Cancer: A Retrospective Study in the SEER Database and China.

    abstract::Background: To identify associated risk factors and develop a predictive nomogram for the early death of metastatic gastric cancer patients. Methods: A total of 4575 patients in the SEER cohort and 220 patients in the Chinese cohort diagnosed with metastatic gastric cancer in our Cancer Center were obtained. Univariat...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.46563

    authors: Zhu Y,Fang X,Wang L,Zhang T,Yu D

    更新日期:2020-07-14 00:00:00

  • The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer.

    abstract::Junctional adhesion molecule B (JAM-B) is a multifunctional transmembrane protein that plays an important role in tumor progression. JAM-B is significantly upregulated in gastric cancer, melanoma cell metastasis and oral squamous cell carcinoma. JAM-2 may also function as a putative tumor suppressor in the progression...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.40953

    authors: Zhang W,He R,Chen S,Zhang L,Cao G,Yang W,Li J

    更新日期:2020-03-05 00:00:00

  • Predictors of Mastoiditis after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: A Dose-Volume Analysis.

    abstract:BACKGROUND:To identify predictors for development of mastoiditis after intensity-modulated radiation therapy (IMRT) in nasopharyngeal carcinoma (NPC). METHODS:Data for 146 NPC patients treated with IMRT was retrospectively reviewed under institutional ethics committee approval. Clinical factors associated with mastoid...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.13183

    authors: Yao JJ,Zhou GQ,Jin YN,Zhang WJ,Lin L,Yu XL,Shao JY,Ma J,Sun Y

    更新日期:2016-01-08 00:00:00